2014 EASO Position Statement on the Use of Anti-Obesity Drugs
- PMID: 25968960
- PMCID: PMC5644876
- DOI: 10.1159/000430801
2014 EASO Position Statement on the Use of Anti-Obesity Drugs
References
-
- World Health Organisation Fact Sheet No.311 (May 2012) www.who.int./mediacentre/factsheets/fs311/en/.
-
- Frühbeck G. Obesity: screening for the evident in obesity. Nat Rev Endocrinol. 2012;8:570–572. - PubMed
-
- Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo N, Casswell S, Cecchini M, Colagiuri S, Collins T, Ebrahim S, Engelgau M, Galea G, Gaziano T, Geneau R, Haines A, Hospedales J, Jha P, Keeling A, Leeder S, Lincoln P, McKee M, Mackay J, Magnusson R, Moodie R, Mwatsama M, Nishtar S, Norrving B, Patterson D, Piot P, Ralston J, Rani M, Reddy KS, Sassi F, Sheron N, Stuckler D, Suh I, Torode J, Varghese C, Watt J, Lancet NCD Action Group; NCD Alliance Priority actions for the non-communicable disease crisis. Lancet. 2011;377:1438–1447. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
